Neurobiology of Posttraumatic Stress Disorder Dysfunction and Recovery Following Cognitive Processing Therapy

Part of paid clinical trials in Belmont, Massachusetts.

Sponsor
Milissa Kaufman
Study ID
NCT02695953
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Not accepted

Study Details

Posttraumatic stress disorder (PTSD) is a significant personal and societal burden. The purpose of this study is to examine genetic, epigenetic, behavioral, and brain activity changes related to PTSD dysfunction and recovery before and after treatment with Cognitive Processing Therapy.

Key Dates

Start date
Mar 31, 2016
Status verified
Oct 2025
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
130 participants (estimated)

Primary Outcome Measure

Potential Change in Evidence of PTSD symptoms with neuroimaging [ Time Frame: Within 30 days before and again within 30 days after Cognitive Processing Therapy Treatment. ]

Locations (1)

FacilityCityStateZIPSite coordinators
McLean HospitalBelmontMassachusetts02478-

Find similar trials in Belmont, MA

By condition
PTSD (post-traumatic stress disorder)
By specialty
PsychiatryMental healthBehavioral health
By research site
McLean Hospital· Belmont, MA

Related Studies